SUBSCRIBE
SUBSCRIBE
BioCapital

Ranbaxy Laboratories AIDS Drugs Won’t Be Funded by U.S. Program

September 26, 2008 | 
1 min read

Sept. 25 (Bloomberg) -- AIDS drugs made by Ranbaxy Laboratories Ltd. won’t be purchased under an American program to supply medicines to developing countries after the U.S. cited the company for violations in two of its plants.

Asia
MORE ON THIS TOPIC
Podcast
BioSpace at Meeting on the Mesa, WuXi Considers Selling U.S. Facilities, Big Pharma Layoffs, More
October 9, 2024
 · 
1 min read
 · 
Heather McKenzie
United States and China flag together realtions textile cloth fabric texture
BIOSECURE Act
WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow
October 8, 2024
 · 
5 min read
 · 
Ben Hargreaves
Facade of AstraZeneca's office in Shanghai, China
Cardiovascular disease
AstraZeneca Puts $2B On The Line for Preclinical Heart Disease Drug
October 7, 2024
 · 
2 min read
 · 
Tristan Manalac
U.S. and Chinese flags in concrete, broken in the middle
BIOSECURE Act
WuXi Mulls Sale of Some US, European Operations: FT
October 3, 2024
 · 
2 min read
 · 
Tristan Manalac